AAAAAA

   
Results: 1-24 |
Results: 24
Increased mortality after coronary artery bypass graft surgery is associated with increased levels of postoperative creatine kinase-myocardial band isoenzyme release - Results from the GUARDIAN trial
Authors: Klatte, K Chaitman, BR Theroux, P Gavard, JA Stocke, K Boyce, S Bartels, C Keller, B Jessel, A
Citation: K. Klatte et al., Increased mortality after coronary artery bypass graft surgery is associated with increased levels of postoperative creatine kinase-myocardial band isoenzyme release - Results from the GUARDIAN trial, J AM COL C, 38(4), 2001, pp. 1070-1077
The football club doctor system
Authors: Boyce, S
Citation: S. Boyce, The football club doctor system, BR J SP MED, 35(4), 2001, pp. 281-281
Surgical pearl: Hemostat-assisted nail avulsion revisited
Authors: Boyce, S Huang, CC
Citation: S. Boyce et Cc. Huang, Surgical pearl: Hemostat-assisted nail avulsion revisited, J AM ACAD D, 45(6), 2001, pp. 943-944
In vivo cultured skin composed of two-layer collagen sponges with preconfluent cells - Invited discussion
Authors: Boyce, S
Citation: S. Boyce, In vivo cultured skin composed of two-layer collagen sponges with preconfluent cells - Invited discussion, ANN PL SURG, 47(1), 2001, pp. 81-82
A novel collagen-based composite offers effective hemostasis for multiple surgical indications: Results of a randomized controlled trial
Authors: Chapman, WC Sherman, R Boyce, S Malawer, M Hill, A Buncke, G Block, JE Fung, CJ Clavien, P Lee, KF Lebovic, GS Wren, SM Diethrich, E Goldstein, R
Citation: Wc. Chapman et al., A novel collagen-based composite offers effective hemostasis for multiple surgical indications: Results of a randomized controlled trial, SURGERY, 129(4), 2001, pp. 445-450
Intra-amygdala injection of the substance P (NK1 receptor) antagonist L-760735 inhibits neonatal vocalisations in guinea-pigs
Authors: Boyce, S Smith, D Carlson, E Hewson, L Rigby, M O'Donnell, R Harrison, T Rupniak, NMJ
Citation: S. Boyce et al., Intra-amygdala injection of the substance P (NK1 receptor) antagonist L-760735 inhibits neonatal vocalisations in guinea-pigs, NEUROPHARM, 41(1), 2001, pp. 130-137
Differential effects of D-1 and D-2 agonists in MPTP,treated primates: Functional implications for Parkinson's disease
Authors: Boyce, S Rupniak, NMJ Steventon, MJ Iversen, SD
Citation: S. Boyce et al., Differential effects of D-1 and D-2 agonists in MPTP,treated primates: Functional implications for Parkinson's disease, NEUROLOGY, 57(10), 2001, pp. S27-S33
Etoricoxib (MK-0663): Preclinical profile and comparison with other agentsthat selectively inhibit cyclooxygenase-2
Authors: Riendeau, D Percival, MD Brideau, C Charleson, S Dube, D Ethier, D Falgueyret, JP Friesen, RW Gordon, R Greig, G Guay, J Mancini, J Ouellet, M Wong, E Xu, L Boyce, S Visco, D Girard, Y Prasit, P Zamboni, R Rodger, IW Gresser, M Ford-Hutchinson, AW Young, RN Chan, CC
Citation: D. Riendeau et al., Etoricoxib (MK-0663): Preclinical profile and comparison with other agentsthat selectively inhibit cyclooxygenase-2, J PHARM EXP, 296(2), 2001, pp. 558-566
History of the enzyme nomenclature system
Authors: Tipton, K Boyce, S
Citation: K. Tipton et S. Boyce, History of the enzyme nomenclature system, BIOINFORMAT, 16(1), 2000, pp. 34-40
An ulcerated nodule associated with lymphadenopathy - Cat-scratch disease
Authors: Boyce, S Pena, JR Davis, DA
Citation: S. Boyce et al., An ulcerated nodule associated with lymphadenopathy - Cat-scratch disease, ARCH FAM M, 9(4), 2000, pp. 316-317
Analgesic and toxic effects of ABT-594 resemble epibatidine and nicotine in rats
Authors: Boyce, S Webb, JK Shepheard, SL Russell, MGN Hill, RG Rupniak, NMJ
Citation: S. Boyce et al., Analgesic and toxic effects of ABT-594 resemble epibatidine and nicotine in rats, PAIN, 85(3), 2000, pp. 443-450
Warm-coding deficits and aberrant inflammatory pain in mice lacking P2X(3)receptors
Authors: Souslova, V Cesare, P Ding, YN Akopian, AN Stanfa, L Suzuki, R Carpenter, K Dickenson, A Boyce, S Hill, R Nebenius-Oosthuizen, D Smith, AJH Kidd, EJ Wood, JN
Citation: V. Souslova et al., Warm-coding deficits and aberrant inflammatory pain in mice lacking P2X(3)receptors, NATURE, 407(6807), 2000, pp. 1015-1017
Outcome of pregnancies complicated by pre-gestational diabetes mellitus
Authors: Gunton, JE McElduff, A Sulway, M Stiel, J Kelso, I Boyce, S Fulcher, G Robinson, B Clifton-Bligh, P Wilmshurst, E
Citation: Je. Gunton et al., Outcome of pregnancies complicated by pre-gestational diabetes mellitus, AUST NZ J O, 40(1), 2000, pp. 38-43
The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways
Authors: Akopian, AN Souslova, V England, S Okuse, K Ogata, N Ure, J Smith, A Kerr, BJ McMahon, SB Boyce, S Hill, R Stanfa, LC Dickenson, AH Wood, JN
Citation: An. Akopian et al., The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways, NAT NEUROSC, 2(6), 1999, pp. 541-548
Sar in the alkoxy lactone series: The discovery of DFP, a potent and orally active COX-2 inhibitor
Authors: Leblanc, Y Roy, P Boyce, S Brideau, C Chan, CC Charleson, S Gordon, R Grimm, E Guay, J Leger, S Li, CS Riendeau, D Visco, D Wang, Z Webb, J Xu, LJ Prasit, P
Citation: Y. Leblanc et al., Sar in the alkoxy lactone series: The discovery of DFP, a potent and orally active COX-2 inhibitor, BIOORG MED, 9(15), 1999, pp. 2207-2212
The discovery of rofecoxib, [MK 966, Vioxx (R), 4-(4 '-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2 inhibitor
Authors: Prasit, P Wang, Z Brideau, C Chan, CC Charleson, S Cromlish, W Ethier, D Evans, JF Ford-Hutchinson, AW Gauthier, JY Gordon, R Guay, J Gresser, M Kargman, S Kennedy, B Leblanc, Y Leger, S Mancini, J O'Neill, GP Ouellet, M Percival, MD Perrier, H Riendeau, D Rodger, I Tagari, P Therien, M Vickers, P Wong, E Xu, LJ Young, RN Zamboni, R Boyce, S Rupniak, N Forrest, N Visco, D Patrick, D
Citation: P. Prasit et al., The discovery of rofecoxib, [MK 966, Vioxx (R), 4-(4 '-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2 inhibitor, BIOORG MED, 9(13), 1999, pp. 1773-1778
Possible antimigraine mechanisms of action of the 5HT(1F) receptor agonistLY334370
Authors: Shepheard, S Edvinsson, L Cumberbatch, M Williamson, D Mason, G Webb, J Boyce, S Hill, R Hargreaves, R
Citation: S. Shepheard et al., Possible antimigraine mechanisms of action of the 5HT(1F) receptor agonistLY334370, CEPHALALGIA, 19(10), 1999, pp. 851-858
Age-related cognitive deficits, impaired long-term potentiation and reduction in synaptic marker density in mice lacking the beta-amyloid precursor protein
Authors: Dawson, GR Seabrook, GR Zheng, H Smith, DW Graham, S O'Dowd, G Bowery, BJ Boyce, S Trumbauer, ME Chen, HY Van der Ploeg, LHT Sirinathsinghji, DJS
Citation: Gr. Dawson et al., Age-related cognitive deficits, impaired long-term potentiation and reduction in synaptic marker density in mice lacking the beta-amyloid precursor protein, NEUROSCIENC, 90(1), 1999, pp. 1-13
Neurotrophic factors in peripheral nerve injury and regeneration
Authors: Rupniak, NMJ Laird, JMA Boyce, S Hill, RG
Citation: Nmj. Rupniak et al., Neurotrophic factors in peripheral nerve injury and regeneration, HANDB EXP P, 134, 1999, pp. 147-173
Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn
Authors: Boyce, S Wyatt, A Webb, JK O'Donnell, R Mason, G Rigby, M Sirinathsinghji, D Hill, RG Rupniak, NMJ
Citation: S. Boyce et al., Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn, NEUROPHARM, 38(5), 1999, pp. 611-623
Rofecoxib [Vioxx, MK-0966; 4-(4 '-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: A potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles
Authors: Chan, CC Boyce, S Brideau, C Charleson, S Cromlish, W Ethier, D Evans, J Ford-Hutchinson, AW Forrest, MJ Gauthier, JY Gordon, R Gresser, M Guay, J Kargman, S Kennedy, B Leblanc, Y Leger, S Mancini, J O'Neill, GP Ouellet, M Patrick, D Percival, MD Perrier, H Prasit, P Rodger, I Tagari, P Therien, M Vickers, P Visco, D Wang, Z Webb, J Wong, E Xu, LJ Young, RN Zamboni, R Riendeau, D
Citation: Cc. Chan et al., Rofecoxib [Vioxx, MK-0966; 4-(4 '-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: A potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles, J PHARM EXP, 290(2), 1999, pp. 551-560
Onset and progression of motor deficits in motor neuron degeneration (mnd)mice are unaltered by the glycine/NMDA receptor antagonist L-701,324 or the MAO-B inhibitor R(-)-deprenyl
Authors: Boyce, S Webb, JK Carlson, E Rupniak, NMJ Hill, RG Martin, JE
Citation: S. Boyce et al., Onset and progression of motor deficits in motor neuron degeneration (mnd)mice are unaltered by the glycine/NMDA receptor antagonist L-701,324 or the MAO-B inhibitor R(-)-deprenyl, EXP NEUROL, 155(1), 1999, pp. 49-58
An ulcerated nodule associated with lymphadenopathy
Authors: Boyce, S Pena, JR Davis, DA
Citation: S. Boyce et al., An ulcerated nodule associated with lymphadenopathy, ARCH DERMAT, 135(8), 1999, pp. 985
Reversal of behavioural and electrophysiological correlates of experimental peripheral neuropathy by the NK1 receptor antagonist GR205171 in rats
Authors: Cumberbatch, MJ Carlson, E Wyatt, A Boyce, S Hill, RG Rupniak, NMJ
Citation: Mj. Cumberbatch et al., Reversal of behavioural and electrophysiological correlates of experimental peripheral neuropathy by the NK1 receptor antagonist GR205171 in rats, NEUROPHARM, 37(12), 1998, pp. 1535-1543
Risultati: 1-24 |